| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |